Fact CheckerSign in

NCT03486067CompletedPhase 1

A Trial to Determine the Safety of CC-93269, an Antibody, in People who have Multiple Myeloma That Has Returned After a Period of Treatment And is not Responsive After Treatment.

Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Apr 2025

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
112 (actual)
First submitted
5 Sept 2023
Start date
16 May 2018
Lead sponsor
Celgene International II S.a.r.l.
NCT number
NCT03486067
EU CT number
2023-506564-14-00
EudraCT number
2017-003448-19

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 112
  • 19 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (19)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universitaetsklinikum Erlangen AöR
Coordinator of this site? Confirm its status
ErlangenGermanyCompleted
Universitaetsklinikum Heidelberg AöR
Coordinator of this site? Confirm its status
HeidelbergGermanyCompleted
Technical University Of Munich School Of Medicine
Coordinator of this site? Confirm its status
MunichGermanyCompleted
Universitaetsklinikum Tuebingen AöR
Coordinator of this site? Confirm its status
TuebingenGermanyCompleted
Institut Catala d'Oncologia
Coordinator of this site? Confirm its status
BadalonaSpainCompleted
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital General Universitario Gregorio Marañón
Coordinator of this site? Confirm its status
MadridSpainCompleted
Clínica Universidad de navarra
Coordinator of this site? Confirm its status
PamplonaSpainCompleted
Hospital Universitario De Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainCompleted
Hospital Universitario Marqués de Valdecilla
Coordinator of this site? Confirm its status
SantanderSpainCompleted
Hospital Universitario Dr. Peset Aleixandre
Coordinator of this site? Confirm its status
ValenciaSpainCompleted
Hospital Universitario Y Politecnico La Fe
Coordinator of this site? Confirm its status
ValenciaSpainCompleted
Azienda Ospedaliera Papa Giovanni XXIII
Coordinator of this site? Confirm its status
BergamoItalyCompleted
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l
Coordinator of this site? Confirm its status
MeldolaItalyCompleted
Humanitas Research Hospital
Coordinator of this site? Confirm its status
RozzanoItalyCompleted
Sahlgrenska University Hospital-Vastra Gotalandsregionen
Coordinator of this site? Confirm its status
GoteborgSwedenCompleted
Karolinska University Hospital
Coordinator of this site? Confirm its status
HuddingeSwedenCompleted
Region Skane Skanes Universitetssjukhus
Coordinator of this site? Confirm its status
LundSwedenCompleted
Uppsala University Hospital
Coordinator of this site? Confirm its status
UppsalaSwedenCompleted

This page is information, not medical advice. Discuss any trial with your doctor.